ATE348892T1 - Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen - Google Patents

Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen

Info

Publication number
ATE348892T1
ATE348892T1 AT01931274T AT01931274T ATE348892T1 AT E348892 T1 ATE348892 T1 AT E348892T1 AT 01931274 T AT01931274 T AT 01931274T AT 01931274 T AT01931274 T AT 01931274T AT E348892 T1 ATE348892 T1 AT E348892T1
Authority
AT
Austria
Prior art keywords
protease
pneumoniae
chlamydia
strain
host
Prior art date
Application number
AT01931274T
Other languages
English (en)
Inventor
Andrew D Murdin
Raymond P Oomen
Joe Wang
Pamela Dunn
Original Assignee
Sanofi Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Ltd filed Critical Sanofi Pasteur Ltd
Application granted granted Critical
Publication of ATE348892T1 publication Critical patent/ATE348892T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
AT01931274T 2000-05-08 2001-05-08 Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen ATE348892T1 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US20267200P 2000-05-08 2000-05-08
US20785200P 2000-05-30 2000-05-30
US21180100P 2000-06-16 2000-06-16
US21179800P 2000-06-16 2000-06-16
US21179600P 2000-06-16 2000-06-16
US21179700P 2000-06-16 2000-06-16
US21204400P 2000-06-16 2000-06-16
US23533500P 2000-09-26 2000-09-26
US23536100P 2000-09-26 2000-09-26
US23539800P 2000-09-26 2000-09-26

Publications (1)

Publication Number Publication Date
ATE348892T1 true ATE348892T1 (de) 2007-01-15

Family

ID=27581138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01931274T ATE348892T1 (de) 2000-05-08 2001-05-08 Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen

Country Status (6)

Country Link
EP (1) EP1282718B1 (de)
AT (1) ATE348892T1 (de)
AU (1) AU2001258105A1 (de)
CA (1) CA2408199A1 (de)
DE (1) DE60125350T2 (de)
WO (1) WO2001085972A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
WO2000011180A1 (en) 1998-08-20 2000-03-02 Connaught Laboratories Limited NUCLEIC ACID MOLECULES ENCODING POMP91A PROTEIN OF $i(CHLAMYDIA)
WO2000011181A1 (en) 1998-08-20 2000-03-02 Connaught Laboratories Limited NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA)
US6649370B1 (en) 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6607730B1 (en) 1998-11-02 2003-08-19 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1135501A1 (de) 1998-12-01 2001-09-26 Aventis Pasteur Limited Chlamydia antigene, dafür kodierende dna und deren verwendung
KR20070108263A (ko) 1998-12-08 2007-11-08 코릭사 코포레이션 클라미디아 감염을 치료 및 진단하기 위한 조성물 및 이를포함하는 약제학적 조성물 및 진단 키트
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7297341B1 (en) 1998-12-23 2007-11-20 Sanofi Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
US6808713B1 (en) 1998-12-28 2004-10-26 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
JP2002541766A (ja) 1998-12-28 2002-12-10 アベンティス、パストゥール、リミテッド クラミジア抗原および対応するdna断片ならびにその使用
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
EP2172214A3 (de) 1999-03-12 2011-03-16 Aventis Pasteur Limited Chlamydia-Antigene und entsprechende DNA-Fragmente sowie Verwendungen davon
DE60036698T2 (de) 1999-05-03 2008-07-24 Sanofi Pasteur Ltd., Toronto Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
CA2385325C (en) 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
CA2395499C (en) 1999-12-22 2011-10-25 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20030175700A1 (en) 2000-04-21 2003-09-18 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
AU2001258105A1 (en) 2000-05-08 2001-11-20 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
DE60139690D1 (de) 2000-07-03 2009-10-08 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae
US20030059896A1 (en) * 2000-12-21 2003-03-27 Shire Biochem Inc. Novel chlamydia antigens and corresponding DNA fragments
CN102438650A (zh) 2009-03-06 2012-05-02 诺华有限公司 衣原体抗原

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU762606B2 (en) * 1997-11-21 2003-06-26 Genset S.A. Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
CA2350775A1 (en) 1998-11-12 2000-05-18 The Regents Of The University Of California Chlamydia pneumoniae genome sequence
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
KR20070108263A (ko) 1998-12-08 2007-11-08 코릭사 코포레이션 클라미디아 감염을 치료 및 진단하기 위한 조성물 및 이를포함하는 약제학적 조성물 및 진단 키트
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
DE60036698T2 (de) 1999-05-03 2008-07-24 Sanofi Pasteur Ltd., Toronto Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
CA2385325C (en) 1999-09-20 2012-04-10 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
CA2395499C (en) 1999-12-22 2011-10-25 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20030175700A1 (en) 2000-04-21 2003-09-18 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
AU2001258105A1 (en) 2000-05-08 2001-11-20 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
DE60139690D1 (de) 2000-07-03 2009-10-08 Novartis Vaccines & Diagnostic Immunisierung gegen chlamydia pneumoniae

Also Published As

Publication number Publication date
DE60125350D1 (de) 2007-02-01
DE60125350T2 (de) 2007-07-12
AU2001258105A1 (en) 2001-11-20
WO2001085972A2 (en) 2001-11-15
WO2001085972A3 (en) 2002-08-08
EP1282718A2 (de) 2003-02-12
EP1282718B1 (de) 2006-12-20
CA2408199A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
ATE348892T1 (de) Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
WO2002018595A3 (en) Moraxella polypeptides and corresponding dna fragments and uses thereof
WO2001074863A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075112A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001046225A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075111A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075114A3 (en) Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
MXPA04004561A (es) Distribuidor de aire para sistema de biolixiviacion.
Bannantine et al. Development and use of a partial Mycobacterium avium subspecies paratuberculosis protein array
ATE417106T1 (de) Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
Goswami et al. Molecular Cloning ofClostridium perfringensEpsilon-Toxin Gene and Its High Level Expression inE. coli
DK1274853T3 (da) Materialer og fremgangsmåder, der angår immunreaktioner på fusionsproteiner
EP1792995A3 (de) Chlamydia Antigene, entsprechende DNS Fragmente und ihre Verwendungen
WO2001092493A3 (en) 21956 and 25856, human aminopeptidases and uses thereof
WO2003031594A3 (en) Nucleotide and amino acid sequences relating to respiratory diseases and obesity
WO2000006742A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
MXPA01004353A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
WO2003029434A3 (en) Novel molecules of the hkid-1-related protein family and uses thereof
WO2000026239A3 (en) $i(chlamydia) antigens and corresponding dna fragments and uses thereof
WO2001046226A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000011183A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2002002771A3 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
WO2002012475A3 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
WO2000006743A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000026237A3 (en) Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties